Relationship of Mitochondrial DNA Oxidation and Content with Metabolic Syndrome and Cardiovascular Risk in Obesity Phenotypes

被引:1
|
作者
Rojo, Mailen [1 ,2 ]
Perez, Hernan [2 ,3 ]
Millan, Andrea Liliana [1 ,2 ]
Pautasso, Maria Constanza [2 ]
Frechtel, Gustavo Daniel [2 ,3 ,4 ]
Cerrone, Gloria Edith [1 ,2 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol Biotecnol & Genet, Buenos Aires, Argentina
[2] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Buenos Aires, Argentina
[3] Hosp Clin Jose San Martin, Serv Nutr, Buenos Aires, Argentina
[4] Inst Univ Ciencias Salud, Fdn Hctor Alejandro H A Barcelo, Buenos Aires, Argentina
关键词
COPY NUMBER; INSULIN-RESISTANCE; FISSION; FUSION; RATIO;
D O I
10.1155/2024/3008093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Obesity, chronic inflammation, and oxidative stress can influence mitochondrial DNA (mtDNA) content. Our objective was to evaluate the oxidation level and content of mtDNA and its relationship with metabolic parameters in metabolically healthy obese (MHO) compared to metabolically unhealthy obese (MUO) and normal weight (NW) controls. Materials and Methods. We studied 94 NW, 95 MHO, and 97 MUO individuals between 18 and 80 years old. Relative mtDNA content and mtDNA oxidation level (8-oxoguanine, 8-OxoG) were determined in peripheral blood leukocytes by the SYBR Green method of real-time PCR. One-way ANOVA and Tukey test were used to compare biochemical, clinical, and anthropometric characteristics, as well as mtDNA content and 8-OxoG. Results. A progressive decrease in mtDNA content was observed between NW, MHO, and MUO with significant differences in MUO vs. NW (p: 0.04). An increase in 8-OxoG was observed in MUO patients compared to the other groups (MUO vs. MHO p: 0.01; MUO vs. NW p: 0.04). mtDNA content was directly correlated with HDL-c (p<0.01) and inversely with waist circumference (p: 0.01) and LDL-c (p: 0.05). mtDNA content decreased, and the oxidation level increased concomitantly with the presence of obesity, the number of MS components, higher coronary risk, and insulin resistance parameters. Conclusion. MHO presented a similar mtDNA oxidation level to NW and mtDNA content to the MUO, placing the MHO individuals as having an intermediate phenotype. Changes in mtDNA content and oxidation were correlated to the lipid profile related to obesity and/or MS presence, probably associated with oxidative stress and chronic low-grade inflammation.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Obesity, the metabolic syndrome, and cardiovascular disease
    Vega, GL
    AMERICAN HEART JOURNAL, 2001, 142 (06) : 1108 - 1116
  • [22] Obesity, metabolic syndrome, and cardiovascular disease
    Aggoun, Yacine
    PEDIATRIC RESEARCH, 2007, 61 (06) : 653 - 659
  • [23] Obesity, metabolic syndrome, and cardiovascular disease
    Grundy, SM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2595 - 2600
  • [24] Defective mitochondrial biogenesis - A hallmark of the high cardiovascular risk in the metabolic syndrome?
    Nisoli, Enzo
    Clementi, Emilio
    Carruba, Michele O.
    Moncada, Salvador
    CIRCULATION RESEARCH, 2007, 100 (06) : 795 - 806
  • [25] Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome
    Anna Krentowska
    Agnieszka Łebkowska
    Małgorzata Jacewicz-Święcka
    Justyna Hryniewicka
    Monika Leśniewska
    Agnieszka Adamska
    Irina Kowalska
    Endocrine, 2021, 72 : 400 - 410
  • [26] Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome
    Krentowska, Anna
    Lebkowska, Agnieszka
    Jacewicz-Swiecka, Malgorzata
    Hryniewicka, Justyna
    Lesniewska, Monika
    Adamska, Agnieszka
    Kowalska, Irina
    ENDOCRINE, 2021, 72 (02) : 400 - 410
  • [27] Obesity, Metabolic Syndrome, and Cardiovascular Disease
    Yacine Aggoun
    Pediatric Research, 2007, 61 : 653 - 659
  • [28] Cardiovascular outcomes for obesity and metabolic syndrome
    Vega, GL
    OBESITY RESEARCH, 2002, 10 : 27S - 32S
  • [29] Body composition phenotypes in pathways to obesity and the metabolic syndrome
    Dulloo, A. G.
    Jacquet, J.
    Solinas, G.
    Montani, J-P
    Schutz, Y.
    INTERNATIONAL JOURNAL OF OBESITY, 2010, 34 : S4 - S17
  • [30] Body composition phenotypes in pathways to obesity and the metabolic syndrome
    A G Dulloo
    J Jacquet
    G Solinas
    J-P Montani
    Y Schutz
    International Journal of Obesity, 2010, 34 : S4 - S17